Home › Funds › Amova Asset Management Americas, Inc. › BEAM

Amova Asset Management Americas, Inc. position in BEAM

BEAM THERAPEUTICS INC · Health Care

Amova Asset Management Americas, Inc. reported holding 3,349,244 shares of BEAM (BEAM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$81.8M, representing 1.02% of its reported portfolio and ranking #31 among its reported holdings. Amova Asset Management Americas, Inc. has disclosed BEAM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.35M sh
Reported value held$81.76M
Portfolio Weight1.02%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Amova Asset Management Americas, Inc.'s BEAM position evolved

Amova Asset Management Americas, Inc. first disclosed a stake in BEAM in Q3 2023 at 1,642,180 shares (US$39.5M). The position peaked in Q4 2025 at 4,409,300 shares, worth US$122.2M. Across 13 filings, Amova Asset Management Americas, Inc. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,349,244 shares valued at US$81.8M — a reduction of -105,799 shares quarter over quarter.. Notable position changes include a 44% increase in Q4 2023 (shares rose 22% over the following quarter), a 60% increase in Q3 2024 (shares rose 1% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.64M $39.46M New
Q4 2023 2.36M $64.09M Add
Q1 2024 2.36M $77.89M Hold
Q2 2024 2.22M $52.07M Reduce
Q3 2024 3.55M $87.04M Add
Q4 2024 3.96M $98.11M Add
Q1 2025 4.27M $83.27M Add
Q2 2025 4.73M $80.40M Add
Q3 2025 4.83M $117.24M Add
Q4 2025 4.41M $122.18M Reduce
Q1 2026 3.83M $91.16M Reduce
Q2 2026 3.46M $118.54M Reduce
Q3 2026 3.35M $81.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BEAM and 13F data

BEAM (BEAM THERAPEUTICS INC) is a Health Care company. 30 other funds we track also report a position in BEAM — the largest reported positions include Farallon Capital Management (US$351.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$351.3M), ARK Invest (US$288.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BEAM

All BEAM fund holders →

FAQ

How long has Amova Asset Management Americas, Inc. held BEAM?

Amova Asset Management Americas, Inc. has disclosed BEAM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Amova Asset Management Americas, Inc.'s current position in BEAM?

As of Q3 2026, Amova Asset Management Americas, Inc. holds 3.35M shares of BEAM (BEAM THERAPEUTICS INC), valued at $81.76M, representing 1.02% of its reported portfolio and ranking #31.

Has Amova Asset Management Americas, Inc. been buying or selling BEAM?

In the latest 13F filing (Q3 2026), Amova Asset Management Americas, Inc. reduced its position in BEAM. The position peaked in Q4 2025 at 4.41M shares.

Which other funds hold BEAM?

Other major institutional holders of BEAM include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., ARK Invest, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.